Conformational and SAR analysis of NAALADase and PSMA inhibitors.
D000970:Antineoplastic Agents / Q000737:chemistry*; D045744:Cell Line, Tumor; D019277:Entropy; D043425:Glutamate Carboxypeptidase II / Q000037:antagonists & inhibitors*; D006801:Humans; D020128:Inhibitory Concentration 50; D008024:Ligands; D008958:Models, Molecular; D008968:Molecular Conformation; D009010:Monte Carlo Method; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology; D017430:Prostate-Specific Antigen / Q000037:antagonists & inhibitors*; D011485:Protein Binding; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D008024:Ligands; D010455:Peptides; D043425:Glutamate Carboxypeptidase II; D017430:Prostate-Specific Antigen